Document:

EX-10.6

 Exhibit 10.6 

INDEMNITY AGREEMENT 
 THIS INDEMNITY
AGREEMENT (this “Agreement”) is made as of October 9, 2020. 
 Between: 

 

	(1)	 TPG PACE BENEFICIAL FINANCE CORP., an exempted company incorporated under the laws of the Cayman Islands
with registered office at P.O. Box 309, Ugland House, KYI-1104, Grand Cayman, Cayman Islands (the “Company”); and 

 

	(2)	 the undersigned (“Indemnitee”). 

Whereas: 
  

	(A)	 Highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers
or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such
corporations; 

  

	(B)	 The board of directors of the Company (the “Board”) has determined that, in order to attract
and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of
such insurance has been a customary and widespread practice among publicly traded corporations and other business enterprises, the Company believes that, given current market conditions and trends, such insurance may be available to it in the future
only at higher premiums and with more exclusions. At the same time, directors, officers and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to,
among other things, matters that traditionally would have been brought only against the Company or business enterprise itself. The amended and restated articles of association of the Company (the “Articles”) provide for the
indemnification of the officers and directors of the Company. The Articles expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and
members of the board of directors, officers and other persons with respect to indemnification, hold harmless, exoneration, advancement and reimbursement rights; 

 

	(C)	 The uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting
and retaining such persons; 

  

	(D)	 The Board has determined that the increased difficulty in attracting and retaining such persons is detrimental
to the best interests of the Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future; 

	(E)	 It is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold
harmless, exonerate and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so protected against
liabilities; 

  

	(F)	 This Agreement is a supplement to and in furtherance of the Articles and any resolutions adopted pursuant
thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; 

  

	(G)	 Indemnitee may not be willing to serve as an officer or director, advisor or in another capacity without
adequate protection, and the Company desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he be so indemnified; and

 NOW, THEREFORE, in consideration of the premises and the covenants contained herein and subject to the provisions of the letter
agreement dated as of October 9, 2020 between the Company and Indemnitee pursuant to the Underwriting Agreement between the Company and the Underwriters in connection with the Company’s initial public offering, the Company and Indemnitee
do hereby covenant and agree as follows: 
 TERMS AND CONDITIONS 

 

	1	 SERVICES TO THE COMPANY 

Indemnitee will serve or continue to serve as an officer, director, advisor, key employee or in any other capacity of the Company, as
applicable, for so long as Indemnitee is duly elected, appointed or retained or until Indemnitee tenders his resignation. 
  

	2	 DEFINITIONS 

As used in this Agreement: 
  

	2.1	 References to “agent” shall mean any person who is or was a director, officer or employee of
the Company or a subsidiary of the Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity as a director, officer, employee, advisor, fiduciary or other official of another
corporation, partnership, limited liability company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company. 

 

	2.2	 The terms “Beneficial Owner” and “Beneficial Ownership” shall have the
meanings set forth in Rule 13d-3 promulgated under the Exchange Act (as defined below) as in effect on the date hereof. 

 

	2.3	 A “Change in Control” shall be deemed to occur upon the earliest to occur after the date of
this Agreement of any of the following events: 

  
 2 

	 	(a)	 Acquisition of Shares by Third Party. Other than an affiliate of TPG Global, LLC, any Person (as defined
below) is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company’s then outstanding securities entitled to vote generally in
the election of directors, unless (1) the change in the relative Beneficial Ownership of the Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding shares entitled to vote generally in the
election of directors, or (2) such acquisition was approved in advance by the Continuing Directors (as defined below) and such acquisition would not constitute a Change in Control under part (c) of this definition; 

 

	 	(b)	 Change in Board of Directors. Individuals who, as of the date hereof, constitute the Board, and any new
director whose election by the Board or nomination for election by the Company’s shareholders was approved by a vote of at least two thirds of the directors then still in office who were directors on the date hereof or whose election for
nomination for election was previously so approved (collectively, the “Continuing Directors”), cease for any reason to constitute at least a majority of the members of the Board; 

 

	 	(c)	 Corporate Transactions. The effective date of a merger, share exchange, asset acquisition, share
purchase, reorganization or similar business combination, involving the Company and one or more businesses (a “Business Combination”), in each case, unless, following such Business Combination: (1) all or substantially all of
the individuals and entities who were the Beneficial Owners of securities entitled to vote generally in the election of directors immediately prior to such Business Combination beneficially own, directly or indirectly, more than 51% of the combined
voting power of the then outstanding securities of the Company entitled to vote generally in the election of directors resulting from such Business Combination (including, without limitation, a corporation which as a result of such transaction owns
the Company or all or substantially all of the Company’s assets either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination, of the securities
entitled to vote generally in the election of directors; (2) other than an affiliate of TPG Global, LLC, no Person (excluding any corporation resulting from such Business Combination) is the Beneficial Owner, directly or indirectly, of 15% or
more of the combined voting power of the then outstanding securities entitled to vote generally in the election of directors of the surviving corporation except to the extent that such ownership existed prior to the Business Combination; and
(3) at least a majority of the Board of Directors of the corporation resulting from such Business Combination were Continuing Directors at the time of the execution of the initial agreement, or of the action of the Board of Directors, providing
for such Business Combination; 

  
 3 

	 	(d)	 Liquidation. The approval by the shareholders of the Company of a complete liquidation of the Company or
an agreement or series of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than factoring the Company’s current receivables or escrows due (or, if such approval is not
required, the decision by the Board to proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions); or 

  

	 	(e)	 Other Events. There occurs any other event of a nature that would be required to be reported in response
to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement.

  

	2.4	 “Corporate Status” describes the status of a person who is or was a director, officer,
trustee, general partner, managing member, fiduciary, employee or agent of the Company or of any other Enterprise (as defined below) which such person is or was serving at the request of the Company. 

 

	2.5	 “Cayman Court” shall mean the Courts of the Cayman Islands. 

 

	2.6	 “Disinterested Director” shall mean a director of the Company who is not and was not a party
to the Proceeding (as defined below) in respect of which indemnification is sought by Indemnitee. 

  

	2.7	 “Enterprise” shall mean the Company and any other corporation, constituent corporation
(including any constituent of a constituent) absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party, limited liability company, partnership, joint venture, trust, employee benefit plan or
other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, general partner, managing member, fiduciary, employee or agent. 

 

	2.8	 “Exchange Act” shall mean the United States Securities Exchange Act of 1934, as amended.

  

	2.9	 “Expenses” shall include all direct and indirect costs, fees and expenses of any type or
nature whatsoever, including, without limitation, all attorneys’ fees and costs, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, fees of private investigators and professional advisors, duplicating
costs, printing and binding costs, telephone charges, postage, delivery service fees, fax transmission charges, secretarial services and all other disbursements, obligations or expenses in connection with prosecuting, defending, preparing to
prosecute or defend, investigating, being or preparing to be a witness in, settlement or appeal of, or otherwise participating in, a Proceeding (as defined below), including reasonable compensation for time spent by Indemnitee for which he or she is
not otherwise compensated by the Company or any third party. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding (as defined below), including without limitation the principal, premium,

  
 4 

	 	
security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or
the amount of judgments or fines against Indemnitee. 

  

	2.10	 “Independent Counsel” shall mean a law firm or a member of a law firm with significant
experience in matters of corporate law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters
concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements); or (ii) any other party to the Proceeding (as defined below) giving rise to a claim for indemnification hereunder. Notwithstanding
the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or
Indemnitee in an action to determine Indemnitee’s rights under this Agreement. 

  

	2.11	 References to “fines” shall include any excise tax assessed on Indemnitee with respect to any
employee benefit plan; references to “serving at the request of the Company” shall include any service as a director, officer, employee, agent or fiduciary of the Company which imposes duties on, or involves services by, such
director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its participants or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests of the
participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to in this Agreement. 

 

	2.12	 The term “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the
Exchange Act as in effect on the date hereof; provided, however, that “Person” shall exclude: (i) the Company; (ii) any Subsidiaries (as defined below) of the Company; (iii) any employment benefit plan of the Company
or of a Subsidiary (as defined below) of the Company or of any corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of share of the Company; and (iv) any trustee
or other fiduciary holding securities under an employee benefit plan of the Company or of a Subsidiary (as defined below) of the Company or of a corporation owned directly or indirectly by the shareholders of the Company in substantially the same
proportions as their ownership of share of the Company. 

  

	2.13	 The term “Proceeding” shall include any threatened, pending or completed action, suit,
arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil
(including intentional or unintentional tort claims), criminal, administrative, or investigative or related nature, in which Indemnitee was, is, will or might be involved as a party or otherwise by reason of the fact that Indemnitee is or was a
director or officer of the Company, by reason of any action (or failure to act) taken by him or of any action (or failure to act) on his part while acting as a director or officer of the Company, or by reason of the fact that he is or was serving at
the request of the Company as a director, officer, trustee, general partner, managing member, fiduciary, employee or agent of any other Enterprise, in each case 

  
 5 

	 	
whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided under this Agreement.

  

	2.14	 The term “Subsidiary,” with respect to any Person, shall mean any corporation or other entity of
which a majority of the voting power of the voting equity securities or equity interest is owned, directly or indirectly, by that Person. 

  

	3	 INDEMNITY IN THIRD-PARTY PROCEEDINGS 

To the fullest extent permitted by applicable law, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the
provisions of this Section 3 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness or otherwise) in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its
favor. Pursuant to this Section 3, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement (including all interest, assessments and other
charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on his behalf in connection with such Proceeding or any claim,
issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding, had no reasonable cause to believe that his
conduct was unlawful. 
  

	4	 INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY 

To the fullest extent permitted by applicable law, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the
provisions of this Section 4 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness or otherwise) in any Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this
Section 4, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or on his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted
in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. No indemnification, hold harmless or exoneration for Expenses shall be made under this Section 4 in respect of any claim, issue
or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that any court in which the Proceeding was brought or the Cayman Court shall determine upon application that,
despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification, to be held harmless or to exoneration. 

 

	5	 INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL 

Notwithstanding any other provisions of this Agreement except for Section 27, to the extent that Indemnitee is a party to (or a
participant in) and is successful, on the merits or 

  
 6 

 
otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall, to the fullest extent permitted by applicable law, indemnify, hold
harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by him in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but
less than all claims, issues or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law, indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by him or on
his behalf in connection with each successfully resolved claim, issue or matter. If Indemnitee is not wholly successful in such Proceeding, the Company also shall, to the fullest extent permitted by applicable law, indemnify, hold harmless and
exonerate Indemnitee against all Expenses reasonably incurred in connection with a claim, issue or matter related to any claim, issue, or matter on which Indemnitee was successful. For purposes of this Section 5 and without limitation, the
termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. 

 

	6	 INDEMNIFICATION FOR EXPENSES OF A WITNESS 

Notwithstanding any other provision of this Agreement except for Section 27, to the extent that Indemnitee is, by reason of his Corporate
Status, a witness in any Proceeding to which Indemnitee is not a party, he shall, to the fullest extent permitted by applicable law, be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or on his
behalf in connection therewith. 
  

	7	 ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND EXONERATION RIGHTS 

 

	7.1	 Notwithstanding any limitation in Sections 3, 4, or 5, except for Section 27, the Company shall, to the
fullest extent permitted by applicable law, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a
judgment in its favor) against all Expenses, judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines,
penalties and amounts paid in settlement) actually and reasonably incurred by Indemnitee in connection with the Proceeding. No indemnification, hold harmless or exoneration rights shall be available under this Section 7.1 on account of
Indemnitee’s conduct which constitutes a breach of Indemnitee’s duty of loyalty to the Company or its shareholders or is an act or omission not in good faith or which involves intentional misconduct or a knowing violation of the law.

  

	7.2	 Notwithstanding any limitation in Sections 3, 4, 5 or 7.1, except for Section 27, the Company shall, to
the fullest extent permitted by applicable law, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a
judgment in its favor) against all Expenses, judgments, fines, penalties and amounts paid 

  
 7 

	 	
in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement)
actually and reasonably incurred by Indemnitee in connection with the Proceeding. 

  

	8	 CONTRIBUTION IN THE EVENT OF JOINT LIABILITY 

 

	8.1	 To the fullest extent permissible under applicable law, if the indemnification, hold harmless and/or
exoneration rights provided for in this Agreement are unavailable to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying, holding harmless or exonerating Indemnitee, shall pay, in the first instance, the
entire amount incurred by Indemnitee, whether for judgments, liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding without requiring Indemnitee to contribute to such payment,
and the Company hereby waives and relinquishes any right of contribution it may have at any time against Indemnitee. 

  

	8.2	 The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with
Indemnitee (or would be if joined in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee. 

  

	8.3	 The Company hereby agrees to fully indemnify, hold harmless and exonerate Indemnitee from any claims for
contribution which may be brought by officers, directors or employees of the Company other than Indemnitee who may be jointly liable with Indemnitee. 

  

	9	 EXCLUSIONS 

Notwithstanding any provision in this Agreement except for Section 27, the Company shall not be obligated under this Agreement to make any
indemnification, hold harmless or exoneration payment in connection with any claim made against Indemnitee: 
  

	 	(a)	 for which payment has actually been received by or on behalf of Indemnitee under any insurance policy or other
indemnity provision, except with respect to any excess beyond the amount actually received under any insurance policy, contract, agreement, other indemnity provision or otherwise; 

 

	 	(b)	 for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities
of the Company within the meaning of Section 16(b) of the Exchange Act or similar provisions of state statutory law or common law; or 

  

	 	(c)	 except as otherwise provided in Sections 14.5 and 14.6 hereof, prior to a Change in Control, in connection with
any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless
(i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii) the Company provides the indemnification, hold harmless or exoneration payment, in its sole discretion, pursuant to the powers vested
in the Company under applicable law. 

  
 8 

	10	 ADVANCES OF EXPENSES; DEFENSE OF CLAIM 

 

	10.1	 Notwithstanding any provision of this Agreement to the contrary except for Section 27, and to the fullest
extent not prohibited by applicable law, the Company shall pay the Expenses incurred by Indemnitee (or reasonably expected by Indemnitee to be incurred by Indemnitee within three months) in connection with any Proceeding within ten (10) days
after the receipt by the Company of a statement or statements requesting such advances from time to time, prior to the final disposition of any Proceeding. Advances shall be unsecured and interest free. Advances shall be made without regard to
Indemnitee’s ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to be indemnified, held harmless or exonerated under the other provisions of this Agreement. Advances shall include any and all reasonable
Expenses incurred pursuing a Proceeding to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed. To the fullest extent required by applicable law, such
payments of Expenses in advance of the final disposition of the Proceeding shall be made only upon the Company’s receipt of an undertaking, by or on behalf of Indemnitee, to repay the advance to the extent that it is ultimately determined that
Indemnitee is not entitled to be indemnified by the Company under the provisions of this Agreement, the Articles, applicable law or otherwise. This Section 10.1 shall not apply to any claim made by Indemnitee for which an indemnification, hold
harmless or exoneration payment is excluded pursuant to Section 9. 

  

	10.2	 The Company will be entitled to participate in the Proceeding at its own expense. 

 

	10.3	 The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any
Expense, judgment, fine, penalty or limitation on Indemnitee without Indemnitee’s prior written consent. 

  

	11	 PROCEDURE FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION 

 

	11.1	 Indemnitee agrees to notify promptly the Company in writing upon being served with any summons, citation,
subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification, hold harmless or exoneration rights, or advancement of Expenses covered hereunder. The failure of Indemnitee
to so notify the Company shall not relieve the Company of any obligation which it may have to Indemnitee under this Agreement, or otherwise. 

  

	11.2	 Indemnitee may deliver to the Company a written application to indemnify, hold harmless or exonerate Indemnitee
in accordance with this Agreement. Such application(s) may be delivered from time to time and at such time(s) as Indemnitee deems appropriate in his or her sole discretion. Following such a written application for indemnification by Indemnitee,
Indemnitee’s entitlement to indemnification shall be determined according to Section 12.1 of this Agreement. 

  
 9 

	12	 PROCEDURE UPON APPLICATION FOR INDEMNIFICATION 

 

	12.1	 A determination, if required by applicable law, with respect to Indemnitee’s entitlement to
indemnification shall be made in the specific case by one of the following methods, which shall be at the election of Indemnitee: (i) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board (ii) by
Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee; or (iii) by vote of the shareholders by ordinary resolution. The Company will promptly advise Indemnitee in writing with respect to any
determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied. If it is so determined that Indemnitee is entitled to indemnification, payment to
Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall reasonably cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification,
including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably
necessary to such determination. Any costs or Expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company
(irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. 

 

	12.2	 In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant
to Section 12.1 hereof, the Independent Counsel shall be selected as provided in this Section 12.2. The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board), and
Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel” as
defined in Section 2 of this Agreement. If the Independent Counsel is selected by the Board, the Company shall give written notice to Indemnitee advising him of the identity of the Independent Counsel so selected and certifying that the
Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement. In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after
such written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the
Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent
a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection
is withdrawn or a court of competent jurisdiction has determined that such objection is without merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant to Section 11.2 hereof, no
Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee 

  
 10 

	 	
may petition the Cayman Court for resolution of any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the
appointment as Independent Counsel of a person selected by the Cayman Court, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 12.1 hereof. Upon the due
commencement of any judicial proceeding or arbitration pursuant to Section 14.1 of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of
professional conduct then prevailing). 

  

	12.3	 The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and
hold harmless such Independent Counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. 

 

	13	 PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS 

 

	13.1	 In making a determination with respect to entitlement to indemnification hereunder, the person, persons or
entity making such determination shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 11.2 of this Agreement, and the Company
shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of the Company (including by its directors or
Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual
determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable
standard of conduct. 

  

	13.2	 If the person, persons or entity empowered or selected under Section 12 of this Agreement to determine
whether Indemnitee is entitled to indemnification shall not have made a determination within thirty (30) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall be deemed to
have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in
connection with the request for indemnification, or (ii) a final judicial determination that any or all such indemnification is expressly prohibited under applicable law; provided, however, that such
30-day period may be extended for a reasonable time, not to exceed an additional fifteen (15) days, if the person, persons or entity making the determination with respect to entitlement to indemnification
in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto. 

  

	13.3	 The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or
conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect 

  
 11 

	 	
the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best
interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his conduct was unlawful. 

  

	13.4	 For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if
Indemnitee’s action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the directors or officers of the Enterprise in the course of their duties, or on the
advice of legal counsel for the Enterprise, its Board, any committee of the Board or any director, or on information or records given or reports made to the Enterprise, its Board, any committee of the Board or any director, by an independent
certified public accountant or by an appraiser or other expert selected by the Enterprise, its Board, any committee of the Board or any director. The provisions of this Section 13.4 shall not be deemed to be exclusive or to limit in any way the
other circumstances in which Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in this Agreement. 

  

	13.5	 The knowledge and/or actions, or failure to act, of any other director, officer, trustee, partner, managing
member, fiduciary, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. 

 

	14	 REMEDIES OF INDEMNITEE 

 

	14.1	 In the event that (i) a determination is made pursuant to Section 12 of this Agreement that
Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses, to the fullest extent permitted by applicable law, is not timely made pursuant to Section 10 of this Agreement, (iii) no determination
of entitlement to indemnification shall have been made pursuant to Section 12.1 of this Agreement within thirty (30) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made
pursuant to Sections 5, 6, 7 or the last sentence of Section 12.1 of this Agreement within ten (10) days after receipt by the Company of a written request therefor, (v) a contribution payment is not made in a timely manner pursuant to
Section 8 of this Agreement, (vi) payment of indemnification pursuant to Section 3 or 4 of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or
(vii) payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is not made within ten (10) days after receipt by the Company of a written request therefor, Indemnitee shall be entitled to
an adjudication by the Cayman Court to such indemnification, hold harmless, exoneration, contribution or advancement rights. Alternatively, Indemnitee, at his option, may seek an award in arbitration to be conducted by a single arbitrator pursuant
to the Commercial Arbitration Rules of the American Arbitration Association. Except as set forth herein, the provisions of Cayman Islands law (without regard to its conflict of laws rules) shall apply to any such arbitration. The Company shall not
oppose Indemnitee’s right to seek any such adjudication or award in arbitration. 

  
 12 

	14.2	 In the event that a determination shall have been made pursuant to Section 12.1 of this Agreement that
Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 14 shall be conducted in all respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be
prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section 14, Indemnitee shall be presumed to be entitled to be indemnified, held harmless, exonerated to receive advances of
Expenses under this Agreement and the Company shall have the burden of proving Indemnitee is not entitled to be indemnified, held harmless, exonerated and to receive advances of Expenses, as the case may be, and the Company may not refer to or
introduce into evidence any determination pursuant to Section 12.1 of this Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Section 14, Indemnitee shall not be
required to reimburse the Company for any advances pursuant to Section 10 until a final determination is made with respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

  

	14.3	 If a determination shall have been made pursuant to Section 12.1 of this Agreement that Indemnitee is
entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 14, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a
material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law. 

 

	14.4	 The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to
this Section 14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.

  

	14.5	 The Company shall indemnify and hold harmless Indemnitee to the fullest extent permitted by law against all
Expenses and, if requested by Indemnitee, shall (within ten (10) days after the Company’s receipt of such written request) pay to Indemnitee, to the fullest extent permitted by applicable law, such Expenses which are incurred by Indemnitee
in connection with any judicial proceeding or arbitration brought by Indemnitee (i) to enforce his rights under, or to recover damages for breach of, this Agreement or any other indemnification, hold harmless, exoneration, advancement or
contribution agreement or provision of the Articles now or hereafter in effect; or (ii) for recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee, regardless of the outcome and whether Indemnitee
ultimately is determined to be entitled to such indemnification, hold harmless or exoneration right, advancement, contribution or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was not brought by Indemnitee in
good faith). 

  

	14.6	 Interest shall be paid by the Company to Indemnitee at a rate to be agreed between the Company and the
Indemnitee for amounts which the Company indemnifies, holds harmless or exonerates, or is obliged to indemnify, hold harmless or exonerate for the period 

  
 13 

	 	
commencing with the date on which Indemnitee requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement of any Expenses and ending with the date on
which such payment is made to Indemnitee by the Company. 

  

	15	 SECURITY 

Notwithstanding anything herein to the contrary except for Section 27, to the extent requested by Indemnitee and approved by the Board,
the Company may at any time and from time to time provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral. Any such security, once provided to
Indemnitee, may not be revoked or released without the prior written consent of Indemnitee. 
  

	16	 NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION

  

	16.1	 The rights of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to
which Indemnitee may at any time be entitled under applicable law, the Articles, any agreement, a vote of shareholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall
limit or restrict any right of Indemnitee under this Agreement in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) arising out of, or related to, any action taken or omitted by such
Indemnitee in his Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, permits greater indemnification, hold harmless or exoneration rights or
advancement of Expenses than would be afforded currently under the Articles or this Agreement, then this Agreement (without any further action by the parties hereto) shall automatically be deemed to be amended to require that the Company indemnify
Indemnitee to the fullest extent permitted by law. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy
given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

  

	16.2	 The Articles permit the Company to purchase and maintain insurance or furnish similar protection or make other
arrangements including, but not limited to, providing a trust fund, letter of credit, or surety bond (“Indemnification Arrangements”) on behalf of Indemnitee against any liability asserted against him or incurred by or on behalf of
him or in such capacity as a director, officer, employee or agent of the Company, or arising out of his status as such, whether or not the Company would have the power to indemnify him against such liability under the provisions of this Agreement,
as it may then be in effect. The purchase, establishment, and maintenance of any such Indemnification Arrangement shall not in any way limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as
expressly provided herein, and the execution and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under any such
Indemnification Arrangement. 

  
 14 

	16.3	 To the extent that the Company maintains an insurance policy or policies providing liability insurance for
directors, officers, trustees, partners, managing members, fiduciaries, employees, or agents of the Company or of any other Enterprise which such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in
accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, trustee, partner, managing member, fiduciary, employee or agent under such policy or policies. If, at the time the Company receives
notice from any source of a Proceeding as to which Indemnitee is a party or a participant (as a witness or otherwise), the Company has director and officer liability insurance in effect, the Company shall give prompt notice of such Proceeding to the
insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such
Proceeding in accordance with the terms of such policies. 

  

	16.4	 In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment
to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such
rights. 16.5 The Company’s obligation to indemnify, hold harmless, exonerate or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary,
employee or agent of any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification, hold harmless or exoneration payments or advancement of expenses from such Enterprise. Notwithstanding any other provision
of this Agreement to the contrary except for Section 27, (i) Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration, advancement, contribution or insurance coverage
among multiple parties possessing such duties to Indemnitee prior to the Company’s satisfaction and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations under this Agreement
without regard to whether Indemnitee holds, may pursue or has pursued any indemnification, advancement, hold harmless, exoneration, contribution or insurance coverage rights against any person or entity other than the Company. 

 

	17	 DURATION OF AGREEMENT 

All agreements and obligations of the Company contained herein shall continue during the period Indemnitee serves as a director or officer of
the Company or as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which Indemnitee serves at the request of
the Company and shall continue thereafter so long as Indemnitee shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by Indemnitee pursuant to Section 14 of this Agreement) by reason
of his Corporate Status, whether or not he is acting in any such capacity at the time any liability or expense is incurred for which indemnification can be provided under this Agreement. 

  
 15 

	18	 SEVERABILITY 

If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the
validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or
unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (b) such provision or provisions shall be deemed
reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each
portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent
manifested thereby. 
  

	19	 ENFORCEMENT AND BINDING EFFECT 

 

	19.1	 The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations
imposed on it hereby in order to induce Indemnitee to serve as a director, officer or key employee of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director, officer or key employee of the
Company. 

  

	19.2	 Without limiting any of the rights of Indemnitee under the Articles as they may be amended from time to time,
this Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the
subject matter hereof. 

  

	19.3	 The indemnification, hold harmless, exoneration and advancement of expenses rights provided by or granted
pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially
all of the business or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise at the Company’s request, and shall inure to the benefit of
Indemnitee and his or her spouse, assigns, heirs, devisees, executors and administrators and other legal representatives. 

  

	19.4	 The Company shall require and cause any successor (whether direct or indirect by purchase, merger,
consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement
in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. 

  
 16 

	19.5	 The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later
date, may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may enforce this Agreement by seeking, among other things,
injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining
any other relief to which he may be entitled. The Company and Indemnitee further agree that Indemnitee shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and
permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Indemnitee by a Court of competent
jurisdiction and the Company hereby waives any such requirement of such a bond or undertaking. 

  

	20	 MODIFICATION AND WAIVER 

No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties hereto. No waiver of any
of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver. 

 

	21	 NOTICES 

All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given
(i) if delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, or (ii) mailed by certified or registered mail with postage prepaid, on the third (3rd) business day after the
date on which it is so mailed: 
  

	 	(a)	 If to Indemnitee, at the address Indemnitee shall provide in writing to the Company. 

 

	 	(b)	 If to the Company, to: 

TPG Pace Beneficial Finance Corp. 

301 Commerce Street, Suite 3300 

Forth Worth, TX 76102 

Attn: 

Facsimile: 

With a copy, which shall not constitute notice, to: 

Weil, Gotshal & Manges LLP 

767 Fifth Avenue 

New York, NY 10153 

Attn: Alex Lynch, Esq. 

  
 17 

 or to any other address as may have been furnished to Indemnitee in writing
by the Company. 
  

	22	 APPLICABLE LAW AND CONSENT TO JURISDICTION 

This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the
Cayman Islands, without regard to its conflict of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14.1 of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally:
(a) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Cayman Court and not in any other state or federal court in the United States 

of America or any court in any other country; (b) consent to submit to the exclusive jurisdiction of the Cayman Court for purposes of any
action or proceeding arising out of or in connection with this Agreement; (c) waive any objection to the laying of venue of any such action or proceeding in the Cayman Court; and (d) waive, and agree not to plead or to make, any claim that
any such action or proceeding brought in the Cayman Court has been brought in an improper or inconvenient forum, or is subject (in whole or in part) to a jury trial. 
  

	23	 IDENTICAL COUNTERPARTS 

This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which
together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement. 

 

	24	 MISCELLANEOUS 

Use of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate. The headings of the paragraphs of this
Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof. 
  

	25	 PERIOD OF LIMITATIONS 

No legal action shall be brought and no cause of action shall be asserted by or in the right of the Company against Indemnitee,
Indemnitee’s spouse, heirs, executors or personal or legal representatives after the expiration of two years from the date of accrual of such cause of action, and any claim or cause of action of the Company shall be extinguished and deemed
released unless asserted by the timely filing of a legal action within such two-year period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause of action
such shorter period shall govern. 

  
 18 

	26	 ADDITIONAL ACTS 

If for the validation of any of the provisions in this Agreement any act, resolution, approval or other procedure is required, the Company
undertakes to cause such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfil its obligations under this Agreement. 

 

	27	 WAIVER OF CLAIMS TO TRUST ACCOUNT 

Indemnitee hereby agrees that it does not have any right, title, interest or claim of any kind (each, a “Claim”) in or to any
monies in the trust account established in connection with the Company’s initial public offering for the benefit of the Company and holders of shares issued in such offering, and hereby waives any Claim it may have in the future as a result of,
or arising out of, any services provided to the Company and will not seek recourse against such trust account for any reason whatsoever. 

[SIGNATURE PAGE FOLLOWS] 

  
 19 

 IN WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed as of the
day and year first above written. 
  

					
	TPG PACE BENEFICIAL FINANCE CORP.
		
	By:	 	  

		 	Name:	 	Karl Peterson
		 	Title:	 	Non-Executive Chairman and Director
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	

  
 [Signature Page to
Indemnity Agreement] 

 Not Part of Form of Indemnity Agreement 

*** 
 The following officers, directors and
affiliates of the Company separately executed the foregoing Form of Indemnity Agreement on October 9, 2020: 
 TPG Pace Beneficial Finance Sponsor,
Series LLC 
 Karl Peterson 
 David Bonderman 

Maryanne Hancock 
 Chad Leat 

Nancy Mahon 
 Kathleen Philips 

Kneeland Youngblood 
 Michael MacDougall 

Martin Davidson 
 Eduardo TamrazExhibit
10.1

 

EMPLOYMENT
SEPARATION AGREEMENT

 

This
Employment Separation Agreement (the “Agreement”) is made and entered into by and between James B. Boyd (“Executive”)
and Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”), effective as of September, 21 2020
(the “Effective Date”).

 

W
I T N E S S E T H:

 

WHEREAS,
Executive is the President and Chief Financial Officer of the Company; and

 

WHEREAS,
Executive is party to an employment offer letter agreement with the Company, dated August 14, 2017 (the “Offer Letter”),
an Employee Confidential Information and Assignment of Inventions Agreement with the Company, attached as Exhibit A (including
exhibits thereto, and a Change in Control Agreement with the Company, effective as of June 17, 2016 (the “Change in Control
Agreement” and, together with the Offer Letter and the Inventions and Restrictive Covenant Agreement, the “Employment
Agreements”);

 

WHEREAS,
the Company and the Executive have agreed to the termination of Executive’s employment with the Company in accordance with
this Agreement; and

 

WHEREAS,
the Company and Executive wish to set forth herein certain agreements and understandings in this Agreement relating to Executive’s
termination of employment;

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements herein contained, and for other good and valuable consideration,
the legal sufficiency of which is hereby acknowledged, the Company and Executive agree as follows:

 

1.
Employment Separation.

 

(a) Termination
of Employment; Resignation as Officer. Executive’s employment with the Company will terminate, and Executive shall
be deemed to have resigned from service as President and Chief Financial Officer of the Company (and any other positions held
with the Company or any affiliates), effective (i) at 11:59 P.M. Pacific Time on the day before the day another individual
commences service as Chief Financial Officer of the Company, or, if the Chief Executive Officer of the Company (the
“CEO”) desires that Executive remain employed to provide transition services following such date, such
later date as may be agreed to by Executive and the CEO or (ii) on such earlier date as the CEO determines (the
“Termination Date”), subject to the Company’s continued right to terminate the Executive’s
employment due to Executive’s Disability (as defined in the Change in Control Agreement) or for “Cause” (as
defined in the Change in Control Agreement). Executive and the Company are separately entering to a consulting agreement
substantially in the form attached hereto as Exhibit D (the “Consulting Agreement”) relating to
Executive’s provision of certain consulting services following the Termination Date.

 

(b)
Payment of Accrued Amounts. In connection with Executive’s termination of employment, Executive will receive (a)
any unpaid salary earned through the Termination Date and any unused vacation accrued through the Termination Date (payable on
the Termination Date) and (b) reimbursement for any unreimbursed business expenses properly incurred by Executive through the
Termination Date, in accordance with the Company’s expense reimbursement policy (the “Accrued Amounts”).

 

    	1 

    	 

    

(c)
No Further Employee Compensation and Benefits. Other than the payments and benefits specifically set forth in this Agreement,
the Executive agrees that the Company and its subsidiaries and controlled affiliates do not owe Executive any additional payments,
compensation, remuneration, bonuses, incentive compensation (cash or equity-based, including, without limitation, options, restricted
stock and restricted stock units), benefits, warrants, severance, reimbursement of expenses or commissions of any kind whatsoever,
or other similar compensation, including any obligations under the Offer Letter or the Change in Control Agreement, and except
as provided in this Agreement, Executive is not entitled to any further compensation or eligibility for participation in any benefit
plans, agreements, or arrangements maintained or contributed to by the Company or its subsidiaries and other affiliates, if any,
after the Termination Date; provided, however, that the foregoing shall not extend to (a) any vested benefits under
the Company’s 401(k) retirement plan, if any, and the right to elect continuation coverage under the Consolidated Omnibus
Budget Reconciliation Act (“COBRA”), (b) Executive’s rights, if any, to indemnification or advancement
of expenses in accordance with the Company’s certificate of incorporation, bylaws or other corporate governance document,
or any applicable insurance policy or applicable law or any indemnification agreement with Executive, or (c) Executive’s
rights and entitlements with respect to outstanding equity awards, which shall remain subject to the terms and conditions of the
applicable award agreements and plan(s) pursuant to which such awards were granted, as may be amended from time to time, including
by this Agreement.

 

(d)
No Representation as Company Officer. With the exception of the duties and responsibilities set forth in this Agreement,
Executive acknowledges and agrees that he is relieved of all duties and responsibilities for the Company and its subsidiaries
and other affiliates as of the Termination Date, that after the Termination Date, Executive will not have the authority to bind
the Company or any of its subsidiaries or other affiliates, and that after the Termination Date, Executive will not contact the
Company’s stockholders or any past, current, or prospective customers, distributors, manufacturers, partners or suppliers
of the Company or any of its subsidiaries, affiliates or licensees on behalf of the Company or any of its subsidiaries or other
affiliates. Effective as of 11:59 P.M. Pacific Time on the Termination Date, Executive shall cease and be deemed to have resigned
from any and all titles, positions and appointments the Executive holds with any of the Company’s subsidiaries or controlled
affiliates, whether as an officer, director, employee, trustee, committee member or otherwise. Executive agrees to execute any
documents reasonably requested by the Company in accordance with the preceding sentence.

 

(e)
General Release; Continued Employment Terms; Eligibility for Severance Entitlements. Provided Executive signs and delivers
to the Company the general release attached as Exhibit B within twenty-one (21) days after the date Executive first receives it
from the Company (the “General Release”) and does not revoke the General Release within the seven (7) day revocation
period described therein, Executive’s employment with the Company will continue through the Termination Date at the same
salary as in effect on the Effective Date, subject to the terms of the Employment Agreements (as modified by this Agreement),
Executive will be eligible to earn the Severance Entitlements (as that term is defined in Section 1(f) below), and the Company
shall directly pay Executive’s legal fees and costs incurred in the negotiation of this Agreement and the Consulting Agreement
within 60 days of presentation of an invoice therefor, provided that such fees shall not exceed $5,000. Executive acknowledges
and agrees that Executive’s continued employment, his eligibility to earn the Severance Entitlements and the Company’s
agreement to pay up to $5,000 in legal fees and costs incurred in the negotiation of this Agreement and the Consulting Agreement
constitute full and adequate consideration for the General Release.

 

    	2 

    	 

    

 

(f)
Reaffirmation Agreement; Severance Payments; Vesting of Equity Awards. In addition to the Accrued Amounts, subject to Section
2 of this Agreement, if Executive (i) remains employed through the Termination Date and Executive’s employment terminates
pursuant to this Agreement as of the Termination Date (ii) signs, delivers and does not revoke the General Release as set forth
in Section 1(e), and (iii) signs and delivers to the Company the Reaffirmation Agreement attached as Exhibit C (the “Reaffirmation
Agreement”) no earlier than the Termination Date and no later than the second day following the Termination Date or
within twenty-one (21) days after the date Executive first receives the Reaffirmation Agreement from the Company, whichever is
later, and does not revoke the Reaffirmation Agreement within the seven (7) day revocation period described therein, Executive
shall be entitled to the following severance entitlements (collectively referred to herein as the “Severance Entitlements”):
(A) the Company will continue to pay Executive his annual base salary for 12 months following the Termination Date (payable at
the annual rate of $330,000 and paid in accordance with the Company’s normal payroll practices, with the first of such payments
being made on the first payroll date after the Reaffirmation Agreement becomes irrevocable and including any salary payments relating
to the period between the Termination Date and such first payment date), which payments shall continue to Executive’s estate
in the event of his death, (B) Executive’s unvested restricted stock unit (“RSU”) awards that are outstanding
on the Termination Date shall become fully vested as of the date the Reaffirmation Agreement becomes irrevocable (for clarity,
all of Executive’s outstanding RSUs, including any unvested RSUs that become vested pursuant to this Agreement, shall remain
subject to the terms of the governing RSU award agreements and will be settled in accordance with the terms of such award agreements
on the first business day following the six-month anniversary of the date of the Executive’s separation from service (as
that term is used in the RSU award agreements) or, if earlier, Executive’s death), (C) all of Executive’s outstanding
unvested stock options will become fully vested as of the date the Reaffirmation Agreement becomes irrevocable and all of Executive’s
stock options will remain exercisable until the earlier of (x) the one year anniversary of the date Executive ceases providing
consulting services pursuant to the Consulting Agreement and (y) the last day of the option’s full term, and otherwise in
accordance with the terms of the applicable award agreements and plan pursuant to which the stock options were granted, (D) Executive
will remain eligible to earn a prorated portion of his 2020 annual bonus (or the full 2020 annual bonus and a prorated portion
of the 2021 annual bonus if Executive remains employed through January 1, 2021) without regard to the termination of his employment
and notwithstanding the annual bonus not generally being paid to terminated employees, calculated based on Executive’s individual
goals (including transition goals agreed to by the CEO and Executive relating to the period following the Effective Date and ending
on the Termination Date), and with Company-wide goals and all other terms determined, and the bonus paid in cash, in accordance
with the terms of the Company’s annual bonus plan and otherwise as applied to other active senior executives of the Company,
and, with respect to Executive’s annual bonus for the year in which the Termination Date occurs, prorated by multiplying
such earned annual bonus by a fraction, the numerator of which is the number of days in the year in which the Termination Date
occurs through the Termination Date and the denominator of which is 365, and (E) if Executive timely elects continuation coverage
under COBRA, the Company will pay Executive’s COBRA continuation coverage premium for medical, dental and vision benefits
for Executive and his eligible dependents for 12 months following the Termination Date (or, if earlier, until the applicable COBRA
continuation period ends). Executive also acknowledges and agrees that Severance Entitlements constitute full and adequate consideration
for the Reaffirmation Agreement.

 

    	3 

    	 

    

(g)
Rights and Obligations under Offer Letter, Change in Control Agreement and Inventions and Restrictive Covenant Agreement.
The Offer Letter and the Change in Control Agreement will terminate and be of no further force or effect after the Termination
Date. Except for the payments and benefits provided for in this Agreement, Executive acknowledges and agrees that he is not entitled
to any severance payments or benefits under the Offer Letter, the Change in Control Agreement or otherwise as a result of the
termination of his employment. Executive represents that he is in compliance with, and will continue to comply with all obligations
set forth in the Inventions and Restrictive Covenant Agreement in accordance with their terms following the Termination Date,
and that nothing herein or otherwise alters in any way the terms of the Inventions and Restrictive Covenant Agreement or its survival
after the termination of Executive’s employment with the Company (except for the third sentence of Paragraph 8(a) of the
Inventions and Restrictive Covenant Agreement, which the Company hereby waives). Executive further agrees to execute and deliver
the Termination Certification referenced in the Inventions and Restrictive Covenant Agreement; provided, for the avoidance of
doubt, that notwithstanding anything to the contrary in the Termination Certification, Executive will be permitted to keep his
Company-issued laptop, monitor, docking station, mouse and iPad/tablet (subject to his ongoing obligations with respect to Company
confidential information), provided that after the Termination Date he shall not have access to the Company’s internal drives
or network.

 

(h)
Protected Rights; Defend Trade Secrets Act Notification:

 

Notwithstanding
anything to the contrary in the Inventions and Restrictive Covenant Agreement:

 

(i)
Executive is hereby notified that 18 U.S.C. § 1833(b) states as follows:

 

“An
individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a
trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly
or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law;
or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.”

 

Accordingly,
notwithstanding anything to the contrary in this Agreement or the Inventions and Restrictive Covenant Agreement, Executive understands
that he has the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney,
for the sole purpose of reporting or investigating a suspected violation of law. Executive understands that he also has the right
to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and
protected from public disclosure. Executive understands and acknowledges that nothing in this Agreement or the Inventions and
Restrictive Covenant Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade
secrets that are expressly allowed by 18 U.S.C. § 1833(b).

 

    	4 

    	 

    

(ii)
Nothing in this Agreement, the Inventions and Restrictive Covenant Agreement, the General Release or the Reaffirmation Agreement
shall prohibit or interfere with the Executive exercising protected rights, including rights under the National Labor Relations
Act, filing a charge with the Equal Employment Opportunity Commission; reporting possible violations of law to or participating
in an investigation by any federal, state or local government agency or commission such as the National Labor Relations Board,
the Department of Labor, OSHA, the Department of Justice, or the Securities and Exchange Commission. Executive does not need the
Company’s advance permission to file any such charge or report or to participate in any such investigation. Executive does,
however, waive any right to receive any monetary award or benefit resulting from such a charge, report, or investigation related
to any Executive Released Claims, except that Executive may receive and retain a monetary award from a government-administered
whistleblower award program.

 

2.
Failure to Comply with Employment Agreements or Employment Separation Terms. If (i) prior to the Termination Date, Executive
materially violates or otherwise materially breaches the terms of this Agreement or the Employment Agreements, where such breach
remains uncured fifteen days after written notification is provided to the Executive (unless such breach is unable to be cured,
in which case no fifteen day notice period shall be required), or (ii) prior to the Termination Date, Executive is terminated
for “Cause” (as defined in the Change in Control Agreement”) or resigns, or (iii) if Executive has not executed
(or revokes) the General Release or the Reaffirmation Agreement as provided for and within the time limits set forth in Sections
1(e) and 1(f) of this Agreement (any such event, a “Termination Event”), all of Executive’s unexercised
RSUs and all of Executive’s unexercised stock options (whether or not vested) will immediately be forfeited and Executive
will have no further rights with respect to such awards, Executive shall have no rights to the Severance Entitlements, and the
Company shall have no further obligations pursuant to Section 4(b). All other provisions of this Agreement, the General Release,
and the Reaffirmation Agreement (as applicable) shall survive a Termination Event. For purposes of this section, material breach
of this Agreement includes, but is not limited to the following: any failure of Executive, whether due to bad faith or negligence,
to comply with the terms of the Inventions and Restrictive Covenants Agreement.

 

3.
No Admission of Liability. The parties acknowledge and agree that any payments or benefits provided to Executive under
the terms of this Agreement do not constitute an admission by either party or any of their affiliates that they have violated
any law or legal obligation with respect to any aspect of Executive’s employment with the Company.

 

    	5 

    	 

    

4.
Non-Disparagement.

 

(a)
Subject to Section 1(h)(ii), Executive agrees that he will not, directly or indirectly, (A) make any statement, whether in commercial
or non-commercial speech, disparaging or criticizing in any way the Company or any of its subsidiaries or affiliates, or any products
or services offered by any of these entities, or (B) engage in any other conduct or make any other statement that, in each case,
should reasonably be expected to impair the goodwill or reputation of the Company; provided, however, that nothing herein or elsewhere
shall prevent Executive from making truthful disclosures or statements (x) reasonably necessary in connection with any litigation,
arbitration or mediation or (y) as required by law or by any court, arbitrator, governmental body or other person with apparent
authority to require such disclosures or statements. Without limiting the foregoing, Executive acknowledges and agrees that negative,
critical or disparaging statements regarding this Agreement or the circumstances of Executive’s termination will impair
the goodwill and reputation of the Company and shall constitute grounds for a termination pursuant to Section 2(a).

 

(b)
The Company will inform its executive officers with the title of Vice President and above and members of its board of directors,
not to, directly or indirectly, individually or in concert with others, engage in any conduct or make any statement, calculated
or likely to have the effect of undermining, disparaging or otherwise reflecting poorly upon Executive; provided, however, that
nothing herein or elsewhere shall prevent such individual from making truthful disclosures or statements (x) reasonably necessary
in connection with any litigation, arbitration or mediation or (y) as required by law or by any court, arbitrator, governmental
body or other person with apparent authority to require such disclosures or statements.

 

5.
Entire Agreement. The Company and Executive each represents and warrants that no promise or inducement has been offered
or made except as herein set forth and that the consideration stated herein is the sole consideration for this Agreement. This
Agreement (including the exhibits hereto) constitute the complete and entire agreement, and states fully all agreements, understandings,
promises and commitments between the Company and Executive relating to the subject matter hereof. This Agreement supersedes and
cancels any and all other negotiations, understandings and agreements, oral or written, respecting the subject matter hereof,
between Executive and the Company or any of its subsidiaries or other affiliates (other than the Offer Letter and the Change in
Control Agreement, each of which will remain in effect until the Termination Date, and the Inventions and Restrictive Covenant
Agreement, which shall remain in full force and effect indefinitely to the extent by its terms it survives termination of Executive’s
employment, and other than the third sentence of Paragraph 8(a) of the Inventions and Restrictive Covenant Agreement, which the
Company hereby waives); provided, for the avoidance of doubt, that in the event of conflict between this Agreement and any of
the Employment Agreements, this Agreement shall control. This Agreement may not be modified except by an instrument in writing
signed by the party against whom the enforcement of any waiver, change, modification, or discharge is sought.

 

6.
Assignability; Successors; Governing Law. This Agreement is personal to Executive and Executive may not assign, pledge,
delegate or otherwise transfer to any person or entity any of Executive’s rights, obligations or duties under this Agreement.
Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise)
to all or substantially all of the Company’s business and/or assets will assume the obligations under this Agreement and
agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would
be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company”
will include any successor to the Company’s business and/or assets, regardless of whether such party executes and delivers
any assumption agreement, or any other successor that becomes bound by the terms of this Agreement by operation of law. This Agreement
shall be governed by, construed in accordance with, and enforced pursuant to the laws of the State of California without regard
to principles of conflict of laws. Subject to the Arbitration provision below, the Superior Court of Yolo County and/or the United
States District Court for the Eastern District of California shall have exclusive jurisdiction and venue over all controversies;
provided, however, that either Party may seek equitable remedies, including injunctive relief and specific performance,
for the purpose of protecting its intellectual property rights in any court of competent jurisdiction, wherever located.

 

    	6 

    	 

    

7.
Enforceability; Arbitration.

 

(a)
Each of the covenants and agreements set forth in this Agreement are separate and independent covenants, each of which has been
separately bargained for and the parties hereto intend that the provisions of each such covenant shall be enforced to the fullest
extent permissible. Should the whole or any part or provision of any such separate covenant be held or declared invalid, such
invalidity shall not in any way affect the validity of any other such covenant or of any part or provision of the same covenant
not also held or declared invalid. If any covenant shall be found to be invalid but would be valid if some part thereof were deleted
or the period or area of application reduced, then such covenant shall apply with such minimum modification as may be necessary
to make it valid and effective. The failure of either party at any time to require performance by the other party of any provision
hereunder will in no way affect the right of that party thereafter to enforce the same, nor will it affect any other party’s
right to enforce the same, or to enforce any of the other provisions in this Agreement; nor will the waiver by either party of
the breach of any provision hereof be taken or held to be a waiver of any prior or subsequent breach of such provision or as a
waiver of the provision itself.

 

(b)
The Company and Executive each agrees that any and all disputes arising out of the terms of this Agreement, the Exhibits hereto,
any of the matters herein released, and the Inventions and Restrictive Covenant Agreement will be subject to binding confidential
arbitration. “Confidential” means the fact of a dispute, the fact of the arbitration, the details of the arbitration,
and the result shall be kept confidential by the Parties. The arbitration shall be conducted by one arbitrator, under the auspices
of JAMS and under its then-current Streamlined Arbitration Rules and Procedures (if no disputed claim or counterclaim exceeds
$250,000, not including interest or attorneys’ fees), or under its then-current Comprehensive Arbitration Rules and Procedures
(if any disputed claim or counterclaim exceeds $250,000, not including interest or attorneys’ fees). Any arbitration will
be governed by the Federal Arbitration Act (“FAA”) and conducted in a manner consistent with the JAMS Rules,
supplemented by the California Rules of Civil Procedure, to the extent permitted by the FAA. The power of the arbitrator shall
not exceed that possessed by a judge in a Superior Court in California. The arbitrator shall issue a written opinion in support
of his or her decision, stating the legal and factual basis for the decision and the reasoning leading to such decision. The arbitrator
is prohibited from awarding damages or remedies in excess of those allowed by the provisions of this Agreement. The decision and
award of the arbitrator shall be final and binding and judgment on the award so rendered may be entered in any court having jurisdiction.
The arbitration shall be held in Yolo County, California, or a mutually convenient location. The parties further agree that the
prevailing party in any arbitration will be entitled to injunctive relief in any court of competent jurisdiction to enforce the
arbitration award. This paragraph will not prevent either party from seeking provisional relief (including a temporary restraining
order or preliminary injunction) from any court having jurisdiction over the parties and the subject matter of their dispute relating
to Executive’s obligations under this Agreement and the Inventions and Restrictive Covenant Agreement. BY AGREEING TO THIS
BINDING ARBITRATION PROVISION, BOTH EXECUTIVE AND THE COMPANY GIVE UP ALL RIGHTS TO TRIAL BY JURY.

 

    	7 

    	 

    

8.
Counterparts. This Agreement may be executed in counterparts, each of which together constitute one and the same instrument.
Signatures delivered by facsimile or email PDF shall be effective for all purposes.

 

9.
Notices. Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have
been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage
prepaid. In the case of Executive, mailed notices will be addressed to his at the home address which he most recently communicated
to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all
notices will be directed to the attention of the CEO or General Counsel.

 

10.
No Construction against Drafter. No provision of this Agreement or any related document will be construed against or interpreted
to the disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such party having
or being deemed to have structured or drafted such provision.

 

11.
Taxes. Notwithstanding anything to the contrary in this Agreement, the Company may withhold from all amounts payable under
this Agreement all federal, state, local and foreign taxes that are required to be withheld pursuant to any applicable laws and
regulations. Notwithstanding anything to the contrary in this Agreement, Executive and the Company agree that this Agreement shall
be interpreted to comply with or be exempt from Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations
and authoritative guidance promulgated thereunder to the extent applicable (collectively “Section 409A”), and
all provisions of this Agreement shall be construed in a manner consistent with the requirements for avoiding taxes or penalties
under Section 409A. However, the Company makes no representation that any or all of the payments described in this Agreement will
be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such payment.
Executive understands and agrees that Executive shall be solely responsible for the payment of any taxes, penalties, interest
or other expenses incurred by Executive on account of noncompliance with Section 409A and in no event will the Company, any of
its subsidiaries or other affiliates, or any of their respective directors, officers, agents, attorneys, employees, executives,
shareholders, investors, members, managers, trustees, fiduciaries, representatives, principals, accountants, insurers, successors
or assigns be liable for any additional tax, interest or penalties that may be imposed on the Executive under Section 409A or
any damages for failing to comply with Section 409A.

 

[Signatures
appear on following page]

 

    	8 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed and delivered this Employment Separation Agreement as of the day and year set
forth below.

 

	 	Marrone
    Bio Innovations, Inc.
	 	 	 
	 	By:	/s/
    Kevin Helash
	Dated:
    September 21, 2020	Name:	Kevin
    Helash
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	EXECUTIVE
    
	Dated:
    September 21, 2020	 	 
	 	/s/ James B. Boyd
	 	James B. Boyd

 

[Signature
Page to Employment Separation Agreement]

 

    	 

    	 

    

 

Exhibit
A

 

Employee
Confidential Information and Assignment of Inventions Agreement

 

    	 

    	 

    

 

Exhibit
B

 

General
Release

 

This
General Release (“Release”) is entered into as of September 21, 2020, by and between James B. Boyd (“Executive”)
and Marrone Bio Innovations, Inc. (the “Company”). Executive and the Company are sometimes collectively referred
to as the “Parties.”

 

1.
In consideration for Executive’s execution of this Release and Executive’s promises and covenants contained (a) herein
and (b) in the Employment Separation Agreement between the Company and Executive (the “Employment Separation Agreement”),
the Company agrees to provide to Executive the benefit described in Section 1(e) of the Employment Separation Agreement, subject
to the effectiveness of this Release in accordance with paragraph 4 of this Release.

 

2.
Executive hereby reaffirms his promises and covenants set forth in the Employment Separation Agreement, the terms of which Separation
Agreement are incorporated herein by reference in their entirety as though fully set forth herein, including, without limitation,
Executive’s promises and covenants set forth in paragraphs 1, 2, 4, and 7 of the Employment Separation Agreement.

 

3.
Executive, on behalf of himself, his heirs, executors, agents, representatives, and assigns (collectively, the “Releasors”)
hereby fully acquits, releases, waives and discharges the Company, its and their affiliated, related, parent or subsidiary companies,
and its and their predecessors, successors, and present and former officers, directors, committee members, representatives, attorneys,
agents or employees (the “Company Parties”) from any and all claims, obligations, liabilities, complaints,
causes of action, charges, debts, and demands of whatever kind whatsoever, in law or in equity, known or unknown, asserted or
unasserted (“Claims”), which Executive has ever had or now has against the Company Parties, including without
limitation, Claims arising out of or in any way related to Executive’s relationship with any or all of the Company Parties
and all Claims with respect to any aspect of Executive’s employment, compensation, or termination from employment by the
Company (“Executive Released Claims”). Executive Released Claims include, but are not limited to:

 

(i)
all Claims arising from Executive’s employment with the Company or the termination of that employment, including Claims
for wrongful termination or retaliation and the terms and conditions of employment;

 

(ii)
all Claims related to Executive’s compensation or benefits from the Company, including, salary, wages, overtime, meal and
rest breaks, bonuses, commissions, incentive compensation, profit sharing, retirement benefits, paid time off, vacation, sick
leave, leaves of absence, expense reimbursements, equity, severance pay, and fringe benefits;

 

(iii)
all Claims for breach of contract, breach of quasi-contract, promissory estoppel, detrimental reliance, and breach of the implied
covenant of good faith and fair dealing;

 

(iv)
all tort Claims, including Claims for fraud, defamation, slander, libel, disparagement, negligent or intentional infliction of
emotional distress, personal injury, negligence, compensatory or punitive damages, negligent or intentional misrepresentation,
and discharge in violation of public policy;

 

(v)
all federal, state, and local statutory Claims, including Claims for discrimination, harassment, retaliation, attorneys’
fees, medical expenses, experts’ fees, costs and disbursements; and

 

(vi)
any other Claims of any kind whatsoever, arising from the beginning of time until the date Executive signs this Release, in each
case whether based on contract, tort, statute, local ordinance, regulation or any comparable law, public policy or common law
in any jurisdiction.

 

    	 

    	 

    

 

By
way of example and not in limitation of the foregoing, Executive Released Claims include any Claims arising under Title VII of
the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq.; the Civil Rights Act of 1991; the Civil Rights Acts of 1866
and/or 1871, 42 U.S.C. Section 1981; the Americans with Disabilities Act, 42 U.S.C. 12101 et seq., the Age Discrimination
in Employment Act (“ADEA”), 29 U.S.C. § 621 et seq.; the Family Medical Leave Act, 29 U.S.C. § 2601 et
seq.; Executive Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. § 1001 et seq.; the federal
Worker Adjustment Retraining Notification Act (“WARN Act”), 29 U.S.C. § 2102 et seq., the California WARN
Act, California Labor Code § 1400 et seq., the California Fair Employment and Housing Act, Cal. Gov. Code §12900 et
seq., the California Labor Code and the orders of the California Industrial Welfare Commission. Executive and the Company
intend for this release to be enforced to the fullest extent permitted by law. EXECUTIVE UNDERSTANDS AND AGREES THAT THIS RELEASE
CONTAINS A GENERAL RELEASE OF ALL CLAIMS.

 

4.
Executive further unconditionally releases and forever discharges the Company Parties from any and all Claims that Executive may
have as of the date Executive signs this Release arising under the ADEA. By signing this Release, Executive acknowledges and confirms
that: (i) Executive has been advised by the Company to consult with an attorney of Executive’s choice before signing this
Release; (ii) Executive was given no fewer than twenty-one (21) days to consider the terms of this Release, although Executive
may sign it sooner if desired; (iii) Executive is providing this release in exchange for consideration in addition to that to
which Executive is already entitled; (iv) Executive has seven (7) days from the date of signing this Release to revoke this Release
by providing the Company with a written notice of revocation delivered to Linda Moore, General Counsel and Corporate Secretary,
at lmoore@marronebio.com or to the Company’s physical address at 1540 Drew Avenue, Davis, California 95618, in a manner
reasonably calculated to be received by the Company on or before the end of such seven-day period (“Revocation Period”);
(v) this Release will not become effective until the Revocation Period passes without Executive revoking the Agreement; (vi) the
release contained in this paragraph does not apply to rights and claims that may arise after the date on which Executive signs
this Release, and (vii) Executive knowingly and voluntarily accepts the terms of this Release. Executive further agrees that any
change to this Release, whether material or immaterial, will not restart the twenty-one (21) day period for Executive to consider
the terms of this Release.

 

5.
The Releasors and the Company acknowledge that they are aware of the provisions of California Civil Code, Section 1542, which
reads as follows:

 

“A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER
FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT
WITH THE DEBTOR OR RELEASED PARTY.”

 

The
Releasors hereby expressly give up all the benefits of Section 1542 and of any other similar law of this or any other jurisdiction.
The Releasors acknowledge that there may exist claims or facts in addition to or different from those which are now known or believed
by the Releasors to exist and the Releasors agree that it is their intention to fully settle and release such claims, whether
known or unknown, that may exist as of the date of this Release.

 

6.
Notwithstanding anything to the contrary set forth in paragraph 3, 4, or 5 of this Release, the Releasors do not waive, release
or discharge the Company Parties from Executive’s rights, if any, to vested benefits under the Company’s 401(k) retirement
plan or with respect to Executive’s outstanding equity awards, if any; Executive’s rights, if any, to indemnification
or advancement of expenses in accordance with the Company’s certificate of incorporation, bylaws or other corporate governance
document, or any applicable insurance policy or applicable law, including Section 2802 of the California Labor Code; any Claim
which may arise in the future from events or actions occurring after the date that Executive executes this Release; Claims for
worker’s compensation benefits; Claims for unemployment insurance benefits; any Claims that cannot be released in accordance
with applicable law; and any rights created by this Release or the Employment Separation Agreement.

 

    	 

     

    

 

7.
Executive hereby represents that Executive has not filed or commenced any proceeding against any of the Releasees based upon any
Executive Released Claims.

 

8.
Executive warrants that no promise or inducement has been offered for this Release other than as set forth herein and that this
Release is executed without reliance upon any other promises or representations, oral or written. Any modification of this Release
must be made in writing and be signed by Executive and the Company.

 

9.
If any provision of this Release or compliance by Executive or the Company with any provision of the Release constitutes a violation
of any law, or is or becomes unenforceable or void, then such provision, to the extent only that it is in violation of law, unenforceable
or void, will be deemed modified to the extent necessary so that it is no longer in violation of law, unenforceable or void, and
such provision will be enforced to the fullest extent permitted by law. If such modification is not possible, such provision,
to the extent that it is in violation of law, unenforceable or void, will be deemed severable from the remaining provisions of
this Release, which provisions will remain binding on both Executive and the Company. This Release is governed by, and construed
and interpreted in accordance with the laws of the State of California, without regard to principles of conflicts of law. This
Release, together with the Employment Separation Agreement, represents the entire understanding of the Parties with respect to
subject matter herein; no oral representations have been made or relied upon by the Parties. The Company and Executive each agrees
that any and all disputes arising out of the terms of this Agreement, any of the matters herein released, and the Inventions and
Restrictive Covenant Agreement will be subject to binding confidential arbitration. “Confidential” means the fact
of a dispute, the fact of the arbitration, the details of the arbitration, and the result shall be kept confidential by the Parties.
The arbitration shall be conducted by one arbitrator, under the auspices of JAMS and under its then-current Streamlined Arbitration
Rules and Procedures (if no disputed claim or counterclaim exceeds $250,000, not including interest or attorneys’ fees),
or under its then-current Comprehensive Arbitration Rules and Procedures (if any disputed claim or counterclaim exceeds $250,000,
not including interest or attorneys’ fees). Any arbitration will be governed by the Federal Arbitration Act (“FAA”)
and conducted in a manner consistent with the JAMS Rules, supplemented by the California Rules of Civil Procedure, to the extent
permitted by the FAA. The power of the arbitrator shall not exceed that possessed by a judge in a Superior Court in California.
The arbitrator shall issue a written opinion in support of his or her decision, stating the legal and factual basis for the decision
and the reasoning leading to such decision. The arbitrator is prohibited from awarding damages or remedies in excess of those
allowed by the provisions of this Agreement. The decision and award of the arbitrator shall be final and binding and judgment
on the award so rendered may be entered in any court having jurisdiction. The arbitration shall be held in Yolo County, California,
or a mutually convenient location. The parties further agree that the prevailing party in any arbitration will be entitled to
injunctive relief in any court of competent jurisdiction to enforce the arbitration award. This paragraph will not prevent either
party from seeking provisional relief (including a temporary restraining order or preliminary injunction) from any court having
jurisdiction over the parties and the subject matter of their dispute relating to Executive’s obligations under this Agreement
and the Inventions and Restrictive Covenant Agreement. BY AGREEING TO THIS BINDING ARBITRATION PROVISION, BOTH EXECUTIVE AND THE
COMPANY GIVE UP ALL RIGHTS TO TRIAL BY JURY.

 

10.
No action taken by the Parties hereto, or either of them, either previously or in connection with this Release, shall be deemed
or constructed to be: (a) an admission of the truth or falsity of any claims heretofore made; or (b) an acknowledgment or admission
by either party of any fault or liability whatsoever to the other party or to any third party.

 

11.
Each of the Company Parties, other than the Company, is intended to be a third party beneficiary of this Release.

 

[Signatures
appear on following page]

 

    	 

     

    

 

	EXECUTIVE’S
    ACCEPTANCE OF RELEASE
	 
	BEFORE
    SIGNING MY NAME TO THE RELEASE, I STATE THE FOLLOWING: I HAVE READ THE RELEASE, I UNDERSTAND IT AND I KNOW THAT I AM GIVING
    UP IMPORTANT RIGHTS. I HAVE OBTAINED SUFFICIENT INFORMATION TO INTELLIGENTLY EXERCISE MY OWN JUDGMENT. I HAVE BEEN ADVISED
    THAT I SHOULD CONSULT WITH AN ATTORNEY BEFORE SIGNING IT, AND I HAVE SIGNED THE RELEASE KNOWINGLY AND VOLUNTARILY.

 

	 Date
delivered to Executive: September 21, 2020
	 
	 	 
	Executed
    this 21st day of September, 2020.	 
	 	 
	/s/
    James B. Boyd	 
	James
    B. Boyd	 

 

[Signature
Page to General Release Agreement]

 

    	 

     

    

 

Exhibit
C

 

Reaffirmation
Agreement

 

This
Reaffirmation Agreement (the “Reaffirmation Agreement”) is entered into as of [●], 202[●], by and
between James B. Boyd (“Executive”) and Marrone Bio Innovations, Inc. (the “Company”). Executive
and the Company are sometimes collectively referred to as the “Parties.”

 

1.
Executive’s employment with the Company terminated on [●], 202[●] (the “Termination Date”).

 

2.
The purpose of this Reaffirmation Agreement is to effectuate the intent and agreement of the Parties as reflected in the General
Release between the Parties dated as of [●], 202[●] (the “General Release”), by advancing to the
execution date of this Reaffirmation Agreement the effective date of Executive’s general waiver and release of all Claims
against the Released Parties, as set forth in the Release Agreement.

 

3.
In consideration for Executive’s execution of this Reaffirmation Agreement and Executive’s promises and covenants
contained (a) herein and (b) in the Employment Separation Agreement between the Company and Executive (the “Employment
Separation Agreement”), the Company agrees to provide to Executive the benefit described in Section 1(f) of the Employment
Separation Agreement, subject to the effectiveness of this Release in accordance with paragraph 6 of this Release.

 

4.
Executive hereby reaffirms his promises and covenants set forth in the Employment Separation Agreement, the terms of which Separation
Agreement are incorporated herein by reference in their entirety as though fully set forth herein, including, without limitation,
Executive’s promises and covenants set forth in paragraphs 1, 2, 4, and 7 of the Employment Separation Agreement.

 

5.
Accordingly, with his signature below, Executive, on behalf of himself, his heirs, executors, agents, representatives, and assigns
(collectively, the “Releasors”), hereby specifically acknowledges and reaffirms that he the fully acquits,
releases, waives and discharges the Company, its and their affiliated, related, parent or subsidiary companies, and its and their
predecessors, successors, and present and former officers, directors, committee members, representatives, attorneys, agents or
employees (the “Company Parties”) from any and all claims, obligations, liabilities, complaints, causes of
action, charges, debts, and demands of whatever kind whatsoever, in law or in equity, known or unknown, asserted or unasserted
(“Claims”), which Executive has ever had or now has against the Company Parties, including without limitation,
Claims arising out of or in any way related to Executive’s relationship with any or all of the Company Parties and all Claims
with respect to any aspect of Executive’s employment, compensation, or termination from employment by the Company (“Executive
Released Claims”). Executive Released Claims include, but are not limited to:

 

(i)
all Claims arising from Executive’s employment with the Company or the termination of that employment, including Claims
for wrongful termination or retaliation and the terms and conditions of employment;

 

(ii)
all Claims related to Executive’s compensation or benefits from the Company, including, salary, wages, overtime, meal and
rest breaks, bonuses, commissions, incentive compensation, profit sharing, retirement benefits, paid time off, vacation, sick
leave, leaves of absence, expense reimbursements, equity, severance pay, and fringe benefits;

 

(iii)
all Claims for breach of contract, breach of quasi-contract, promissory estoppel, detrimental reliance, and breach of the implied
covenant of good faith and fair dealing;

 

    	 

     

    

 

(iv)
all tort Claims, including Claims for fraud, defamation, slander, libel, disparagement, negligent or intentional infliction of
emotional distress, personal injury, negligence, compensatory or punitive damages, negligent or intentional misrepresentation,
and discharge in violation of public policy;

 

(v)
all federal, state, and local statutory Claims, including Claims for discrimination, harassment, retaliation, attorneys’
fees, medical expenses, experts’ fees, costs and disbursements; and

 

(vi)
any other Claims of any kind whatsoever, arising from the beginning of time until the date Executive signs this Release, in each
case whether based on contract, tort, statute, local ordinance, regulation or any comparable law, public policy or common law
in any jurisdiction.

 

By
way of example and not in limitation of the foregoing, Executive Released Claims include any Claims arising under Title VII of
the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq.; the Civil Rights Act of 1991; the Civil Rights Acts of 1866
and/or 1871, 42 U.S.C. Section 1981; the Americans with Disabilities Act, 42 U.S.C. 12101 et seq., the Age Discrimination
in Employment Act (“ADEA”), 29 U.S.C. § 621 et seq.; the Family Medical Leave Act, 29 U.S.C. § 2601 et
seq.; Executive Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. § 1001 et seq.; the federal
Worker Adjustment Retraining Notification Act (“WARN Act”), 29 U.S.C. § 2102 et seq., the California WARN
Act, California Labor Code § 1400 et seq., the California Fair Employment and Housing Act, Cal. Gov. Code §12900 et
seq., the California Labor Code and the orders of the California Industrial Welfare Commission. Executive and the Company
intend for this release to be enforced to the fullest extent permitted by law. EXECUTIVE UNDERSTANDS AND AGREES THAT THIS RELEASE
CONTAINS A GENERAL RELEASE OF ALL CLAIMS.

 

Executive
understands and agrees that such waiver and release will be effective as to all Claims arising on or before the date he executes
this Reaffirmation Agreement, subject to his effectuation of this Reaffirmation Agreement in the manner set forth in the next
Section hereof. Executive further understands and agrees that he will not be entitled to the consideration provided for in Section
1(f) of the Employment Separation Agreement unless and until Executive executes this Reaffirmation Agreement and the Revocation
Period described in the next Section hereof passes without Executive revoking this Reaffirmation Agreement.

 

6.
Executive further unconditionally releases and forever discharges the Company Parties from any and all Claims that Executive may
have as of the date Executive signs this Reaffirmation Agreement arising under the ADEA. By signing this Reaffirmation Agreement,
Executive acknowledges and confirms that: (i) Executive has been advised by the Company to consult with an attorney of Executive’s
choice before signing this Reaffirmation Agreement; (ii) Executive was given no fewer than twenty-one (21) days to consider the
terms of this Reaffirmation Agreement, although Executive may sign it sooner if desired; (iii) Executive is providing the release
provided for in in this Reaffirmation Agreement is in exchange for consideration in addition to that to which Executive is already
entitled; (iv) Executive has seven (7) days from the date of signing this Reaffirmation Agreement to revoke this Reaffirmation
Agreement by providing the Company with a written notice of revocation delivered to Linda Moore, General Counsel and Corporate
Secretary, at lmoore@marronebio.com or to the Company’s physical address at 1540 Drew Avenue, Davis, California 95618, in
a manner reasonably calculated to be received by the Company on or before the end of such seven-day period (“Revocation
Period”); (v) this Reaffirmation Agreement will not become effective until the Revocation Period passes without Executive
revoking this Reaffirmation Agreement; (vi) the release contained in this Reaffirmation Agreement does not apply to rights and
claims that may arise after the date on which Executive signs this Reaffirmation Agreement, and (vii) Executive knowingly and
voluntarily accepts the terms of this Reaffirmation Agreement. Executive further agrees that any change to this Reaffirmation
Agreement or the Release Agreement, whether material or immaterial, will not restart the twenty-one (21) day period for Executive
to consider the terms of this Reaffirmation Agreement.

 

    	 

     

    

 

7.
The Releasors and the Company acknowledge that they are aware of the provisions of California Civil Code, Section 1542, which
reads as follows:

 

“A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER
FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT
WITH THE DEBTOR OR RELEASED PARTY.”

 

The
Releasors hereby expressly give up all the benefits of Section 1542 and of any other similar law of this or any other jurisdiction.
The Releasors acknowledge that there may exist claims or facts in addition to or different from those which are now known or believed
by the Releasors to exist and the Releasors agree that it is their intention to fully settle and release such claims, whether
known or unknown, that may exist as of the date of this Release.

 

8.
Notwithstanding anything to the contrary set forth in paragraph 5, 6, or 7 of this Release, the Releasors do not waive, release
or discharge the Company Parties from Executive’s rights, if any, to vested benefits under the Company’s 401(k) retirement
plan or with respect to Executive’s outstanding equity awards, if any; Executive’s rights, if any, to indemnification
or advancement of expenses in accordance with the Company’s certificate of incorporation, bylaws or other corporate governance
document, or any applicable insurance policy or applicable law, including Section 2802 of the California Labor Code; any Claim
which may arise in the future from events or actions occurring after the date that Executive executes this Reaffirmation Agreement;
Claims for worker’s compensation benefits; Claims for unemployment insurance benefits; any Claims that cannot be released
in accordance with applicable law; and any rights created by this Reaffirmation Agreement, the General Release or the Employment
Separation Agreement.

 

9.
Executive hereby represents that Executive has not filed or commenced any proceeding against any of the Releasees based upon any
Executive Released Claims.

 

10.
Executive warrants that no promise or inducement has been offered for this Reaffirmation Agreement other than as set forth herein
and that this Reaffirmation Agreement is executed without reliance upon any other promises or representations, oral or written.
Any modification of this Reaffirmation Agreement must be made in writing and be signed by Executive and the Company.

 

11.
If any provision of this Reaffirmation Agreement or compliance by Executive or the Company with any provision of this Reaffirmation
Agreement constitutes a violation of any law, or is or becomes unenforceable or void, then such provision, to the extent only
that it is in violation of law, unenforceable or void, will be deemed modified to the extent necessary so that it is no longer
in violation of law, unenforceable or void, and such provision will be enforced to the fullest extent permitted by law. If such
modification is not possible, such provision, to the extent that it is in violation of law, unenforceable or void, will be deemed
severable from the remaining provisions of this Reaffirmation Agreement, which provisions will remain binding on both Executive
and the Company. This Reaffirmation Agreement is governed by, and construed and interpreted in accordance with the laws of the
State of California, without regard to principles of conflicts of law. This Reaffirmation Agreement, together with the Employment
Separation Agreement, represents the entire understanding of the Parties with respect to subject matter herein; no oral representations
have been made or relied upon by the Parties. The Company and Executive each agrees that any and all disputes arising out of the
terms of this Reaffirmation Agreement, the Exhibits hereto, any of the matters herein released, and the Inventions and Restrictive
Covenant Agreement will be subject to binding confidential arbitration. “Confidential” means the fact of a dispute,
the fact of the arbitration, the details of the arbitration, and the result shall be kept confidential by the Parties. The arbitration
shall be conducted by one arbitrator, under the auspices of JAMS and under its then-current Streamlined Arbitration Rules and
Procedures (if no disputed claim or counterclaim exceeds $250,000, not including interest or attorneys’ fees), or under
its then-current Comprehensive Arbitration Rules and Procedures (if any disputed claim or counterclaim exceeds $250,000, not including
interest or attorneys’ fees). Any arbitration will be governed by the Federal Arbitration Act (“FAA”)
and conducted in a manner consistent with the JAMS Rules, supplemented by the California Rules of Civil Procedure, to the extent
permitted by the FAA. The power of the arbitrator shall not exceed that possessed by a judge in a Superior Court in California.
The arbitrator shall issue a written opinion in support of his or her decision, stating the legal and factual basis for the decision
and the reasoning leading to such decision. The arbitrator is prohibited from awarding damages or remedies in excess of those
allowed by the provisions of this Agreement. The decision and award of the arbitrator shall be final and binding and judgment
on the award so rendered may be entered in any court having jurisdiction. The arbitration shall be held in Yolo County, California,
or a mutually convenient location. The parties further agree that the prevailing party in any arbitration will be entitled to
injunctive relief in any court of competent jurisdiction to enforce the arbitration award. This paragraph will not prevent either
party from seeking provisional relief (including a temporary restraining order or preliminary injunction) from any court having
jurisdiction over the parties and the subject matter of their dispute relating to Executive’s obligations under this Agreement
and the Inventions and Restrictive Covenant Agreement. BY AGREEING TO THIS BINDING ARBITRATION PROVISION, BOTH EXECUTIVE AND THE
COMPANY GIVE UP ALL RIGHTS TO TRIAL BY JURY.

 

12.
No action taken by the Parties hereto, or either of them, either previously or in connection with this Reaffirmation Agreement,
shall be deemed or constructed to be: (a) an admission of the truth or falsity of any claims heretofore made; or (b) an acknowledgment
or admission by either party of any fault or liability whatsoever to the other party or to any third party.

 

13.
Each of the Company Parties, other than the Company, is intended to be a third party beneficiary of this Reaffirmation Agreement.

 

[Signatures
appear on following page]

 

    	 

     

    

  

	EXECUTIVE’S
    ACCEPTANCE OF RELEASE
	 
	BEFORE
    SIGNING MY NAME TO THE REAFFIRMATION AGREEMENT, I STATE THE FOLLOWING: I HAVE READ THE REAFFIRMATION AGREEMENT, I UNDERSTAND
    IT AND I KNOW THAT I AM GIVING UP IMPORTANT RIGHTS. I HAVE OBTAINED SUFFICIENT INFORMATION TO INTELLIGENTLY EXERCISE MY OWN
    JUDGMENT. I HAVE BEEN ADVISED THAT I SHOULD CONSULT WITH AN ATTORNEY BEFORE SIGNING THE REAFFIRMATION AGREEMENT, AND I HAVE
    SIGNED IT KNOWINGLY AND VOLUNTARILY.

 

	 Date
delivered to Executive: [●], 202[●].
	 
	 	 
	Executed
    this ___________ day of [●], 202[●].	 
	 	 
	 	 
	James
B. Boyd
	 

 

[Signature
Page to Reaffirmation Agreement]

 

    	 

     

    

 

Exhibit
D

 

Consulting
Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]